Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert I Fox

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|July 26, 2005
Sjögren's syndromeRobert I Fox
Expert Opinion on Investigational Drugs|January 31, 2003
Sjogren's syndrome: evolving therapiesRobert I Fox
Scandinavian Journal of Rheumatology. Supplement|July 12, 2002
Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systemsRobert I Fox, Michael Stern
Rheumatic Diseases Clinics of North America|July 20, 2016
Sjögren Syndrome: Why Do Clinical Trials Fail?Robert I Fox, Carla M Fox
Clinics in Dermatology|September 13, 2006
Sjögren's syndrome in dermatologyRobert I Fox, Alice Y Liu
Expert Opinion on Emerging Drugs|May 2, 2023
Emerging treatment for Sjögren's disease: a review of recent phase II and III trialsRobert I Fox, Carla M Fox, Sara S McCoy
Rheumatology (Oxford, England)|April 30, 2019
Treatment of Sjögren's syndrome: current therapy and future directionsRobert I Fox, Carla M Fox, Jacques Eric Gottenberg, et al.
The American Journal of Pathology|June 25, 2004
Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificityToshiaki Maruyama, Ichiro Saito, Yoshio Hayashi, et al.
Nature Medicine|December 8, 2007
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challengeMansun Law, Toshiaki Maruyama, Jamie Lewis, et al.
Nature Reviews. Rheumatology|June 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren diseaseManuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|July 26, 2005
Sjögren's syndromeRobert I Fox
Expert Opinion on Investigational Drugs|January 31, 2003
Sjogren's syndrome: evolving therapiesRobert I Fox
Scandinavian Journal of Rheumatology. Supplement|July 12, 2002
Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systemsRobert I Fox, Michael Stern
Rheumatic Diseases Clinics of North America|July 20, 2016
Sjögren Syndrome: Why Do Clinical Trials Fail?Robert I Fox, Carla M Fox
Clinics in Dermatology|September 13, 2006
Sjögren's syndrome in dermatologyRobert I Fox, Alice Y Liu
Expert Opinion on Emerging Drugs|May 2, 2023
Emerging treatment for Sjögren's disease: a review of recent phase II and III trialsRobert I Fox, Carla M Fox, Sara S McCoy
Rheumatology (Oxford, England)|April 30, 2019
Treatment of Sjögren's syndrome: current therapy and future directionsRobert I Fox, Carla M Fox, Jacques Eric Gottenberg, et al.
The American Journal of Pathology|June 25, 2004
Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificityToshiaki Maruyama, Ichiro Saito, Yoshio Hayashi, et al.
Nature Medicine|December 8, 2007
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challengeMansun Law, Toshiaki Maruyama, Jamie Lewis, et al.
Nature Reviews. Rheumatology|June 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren diseaseManuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, et al.
Pageof 1